The Clinical Relevance of the NATALEE Study: Application of the NATALEE Criteria to a Real-World Cohort from Two Large German Breast Cancer Centers

The NATALEE study showed a significant benefit in invasive disease-free survival (iDFS) for patients with HR+/HER2− early breast cancer (eBC) at intermediate and high risk of recurrence who were treated with the CDK4/6 inhibitor Ribociclib in combination with endocrine therapy (ET). This retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Schäffler, Henning, Mergel, Franziska, Pfister, Kerstin, Lukac, Stephan, Fink, Angelina, Veselinovic, Kristina, Rack, Brigitte, Fink, Visnja, Leinert, Elena, Dimpfl, Moritz, Englisch, Alexander, Tegeler, Christian Martin, Seller, Anna, Grischke, Eva-Maria, Hahn, Markus, Volmer, Léa Louise, Engler, Tobias, Frevert, Marie Louise, Taran, Florin Andrei, Janni, Wolfgang, Brucker, Sara Yvonne, Hartkopf, Andreas Daniel, Dannehl, Dominik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671738/
https://www.ncbi.nlm.nih.gov/pubmed/38003555
http://dx.doi.org/10.3390/ijms242216366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671738/
https://www.ncbi.nlm.nih.gov/pubmed/38003555
http://dx.doi.org/10.3390/ijms242216366

Ejemplares similares